PolTREG appoints Dan Shelly as Chief Business Development :

               Gdańsk, Poland – 21 February 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cell...

Related Keywords

Poland , Chris Maggos , Douwe Miedema , Piotr Trzonkowski , Daniel Shelly , Prescient Therapeutics Ltd , University Of Cincinnati , Cohesion Bureau , Poltreg Sa Warsaw Stock Exchange , Global Business Development , Business Development , Warsaw Stock Exchange , Chief Business Development Officer , Multiple Sclerosis , Amyotrophic Lateral Sclerosis , Chief Executive Officer , Strategic Partnerships , Warsaw Stock Exchange Ptg , Oltreg Sa , Cell Therapies , Type 1 Diabetes , Ls , Ar T ,